STANDARD BIOTOOLS INC.
LABNasdaq
$0.89
↑ +4.4%Jul 17 close · end-of-day
Price
1Y↓ -27.8%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$347.4M
Enterprise Value
-$107.8M
P/E
4.5
P/S
4.0
P/B
0.6
EV/EBITDA
—
PEG
—
FCF Yield
-27.2%
Dividend Yield
—
Revenue (TTM)
$86.3M
Net Income (TTM)
$78.2M
Free Cash Flow (TTM)
-$94.5M
Gross Margin
49.6%
Operating Margin
-111.0%
Net Margin
90.7%
ROE
13.9%
ROIC
-71.4%
Debt / Equity
—
Net Cash
$455.2M
Return 1Y
-28.4%
Company profile
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems. The company also sells single cell microfluidics that comprise C1 systems; preparatory analytical instruments; and software solutions.
- CEO
- Michael Egholm
- Sector
- Manufacturing
- Industry
- Measuring And Control Equipment
- Employees
- 620
- Headquarters
- California
- Website
- fluidigm.com
Management & directors
- Mackay SeanSVP & Chief Business Officer
- Egholm MichaelPresident & CEO
- Kim Hanjoon AlexChief Financial Officer
Roles derived from SEC Form 4 filings.
Earnings
LAB Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$21.1M↑ +4.6%
Diluted EPS$0.33↓ -571.4%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $138.1M | $130.6M | $97.9M | $106.3M | $91.0M | $85.3M |
| Gross profit | — | — | $37.1M | $50.5M | $44.9M | $42.5M |
| Operating income | -$51.0M | -$67.5M | -$116.2M | -$76.6M | -$127.5M | -$110.2M |
| Net income | -$53.0M | -$59.2M | -$190.1M | -$74.7M | -$138.9M | -$74.9M |
| Diluted EPS | -$0.74 | -$0.78 | -$2.43 | -$0.94 | -$0.52 | -$0.20 |
| Operating cash flow | -$15.4M | -$44.1M | -$89.4M | -$43.3M | -$143.5M | -$74.3M |
| Free cash flow | -$28.1M | -$57.3M | -$93.2M | -$46.1M | -$151.8M | -$82.6M |
| Gross margin | — | — | 37.8% | 47.4% | 49.3% | 49.9% |
| Operating margin | -36.9% | -51.7% | -118.6% | -72.0% | -140.1% | -129.2% |
| Net margin | -38.4% | -45.4% | -194.1% | -70.2% | -152.6% | -87.8% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $22.5M | $22.1M | $890,000.00 | $20.2M | $21.8M | $19.6M | $23.8M | $21.1M |
| Gross profit | $10.4M | $12.1M | -$1.8M | $11.0M | $10.6M | $9.5M | $11.4M | $11.3M |
| Operating income | -$30.3M | -$26.7M | -$10.3M | -$27.0M | -$25.7M | -$32.9M | -$24.6M | -$12.5M |
| Net income | -$45.7M | -$26.9M | -$34.1M | -$26.0M | -$33.5M | -$34.7M | $19.3M | $127.1M |
| Diluted EPS | -$0.12 | -$0.07 | -$0.06 | -$0.07 | -$0.09 | -$0.09 | $0.05 | $0.33 |
| Operating cash flow | -$39.0M | -$27.9M | -$14.1M | -$30.3M | -$20.7M | -$22.2M | -$1.2M | -$46.6M |
| Free cash flow | -$41.0M | -$30.1M | -$17.4M | -$35.3M | -$22.6M | -$23.1M | -$1.7M | -$47.2M |
| Gross margin | 46.1% | 54.9% | -202.8% | 54.6% | 48.8% | 48.5% | 47.8% | 53.5% |
| Operating margin | -134.5% | -120.9% | -1162.1% | -133.4% | -118.1% | -168.5% | -103.6% | -59.1% |
| Net margin | -203.3% | -122.0% | -3828.3% | -128.7% | -153.7% | -177.4% | 81.0% | 600.9% |
Company news
Jun 8, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-20 | Mackay Sean· SVP & Chief Business Officer | Award | 500,000 | $0.00 | $0.00 | filing |
| 2026-06-18 | Carey Thomas D. | Award | 99,116 | $0.00 | $0.00 | filing |
| 2026-06-18 | Witney Frank | Award | 99,116 | $0.00 | $0.00 | filing |
| 2026-06-18 | Casdin Eli | Award | 99,116 | $0.00 | $0.00 | filing |
| 2026-06-18 | Cox Troy | Award | 99,116 | $0.00 | $0.00 | filing |
| 2026-06-18 | HIBBS KATHY L | Award | 99,116 | $0.00 | $0.00 | filing |
| 2026-06-18 | ELOI FENEL M | Award | 99,116 | $0.00 | $0.00 | filing |
| 2026-05-20 | Egholm Michael· President & CEO | Tax withholding | 97,626 | $1.00 | $97,626.00 | filing |
| 2026-05-20 | Mackay Sean· SVP & Chief Business Officer | Tax withholding | 25,729 | $1.00 | $25,729.00 | filing |
| 2026-05-20 | Kim Hanjoon Alex· Chief Financial Officer | Tax withholding | 18,871 | $1.00 | $18,871.00 | filing |
| 2026-04-06 | Egholm Michael· President & CEO | Tax withholding | 95,014 | $0.91 | $86,272.71 | filing |
| 2026-04-06 | Kim Hanjoon Alex· Chief Financial Officer | Tax withholding | 21,301 | $0.91 | $19,341.31 | filing |
| 2026-04-06 | Kim Hanjoon Alex· Chief Financial Officer | Option exercise | 70,183 | $0.00 | $0.00 | filing |
| 2026-04-06 | Egholm Michael· President & CEO | Option exercise | 196,513 | $0.00 | $0.00 | filing |
| 2026-03-20 | Kim Hanjoon Alex· Chief Financial Officer | Award | 323,173 | $0.00 | $0.00 | filing |
| 2026-03-20 | Mackay Sean· SVP & Chief Business Officer | Award | 272,107 | $0.00 | $0.00 | filing |
| 2026-03-20 | Egholm Michael· President & CEO | Award | 1,042,373 | $0.00 | $0.00 | filing |
| 2026-02-26 | Cox Troy | Award | 57,264 | $1.17 | $66,998.88 | filing |
| 2026-02-26 | Casdin Eli | Award | 52,991 | $1.17 | $61,999.47 | filing |
| 2026-02-26 | Carey Thomas D. | Award | 51,282 | $1.17 | $59,999.94 | filing |
| 2026-02-23 | Egholm Michael· President & CEO | Tax withholding | 66,127 | $1.15 | $76,046.05 | filing |
| 2026-02-23 | Mackay Sean· SVP & Chief Business Officer | Tax withholding | 19,661 | $1.15 | $22,610.15 | filing |
| 2026-02-23 | Kim Hanjoon Alex· Chief Financial Officer | Tax withholding | 12,740 | $1.15 | $14,651.00 | filing |
| 2025-12-04 | Casdin Partners Master Fund, L.P. | Buy | 150,000 | $1.45 | $217,020.00 | filing |
| 2025-12-03 | Casdin Partners Master Fund, L.P. | Buy | 75,000 | $1.44 | $108,037.50 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.